The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 24, 2012

Filed:

Apr. 16, 2010
Applicants:

Edwin Claerebout, Lokeren, BE;

Jozef Vercruysse, Ghent, BE;

Peter Geldhof, Merelbeke, BE;

Isabel Vercauteren, Woubrechtegem, BE;

Veerle DE Maere, Ghent, BE;

Inventors:

Edwin Claerebout, Lokeren, BE;

Jozef Vercruysse, Ghent, BE;

Peter Geldhof, Merelbeke, BE;

Isabel Vercauteren, Woubrechtegem, BE;

Veerle De Maere, Ghent, BE;

Assignee:

Universiteit Gent, Ghent, NL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07H 21/00 (2006.01); C12N 15/30 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to nucleic acid sequences encoding a 30 kDlipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 30 kDlipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, lipoproteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, lipoprotein or antibodies against such lipoprotein.


Find Patent Forward Citations

Loading…